Platelet adhesion to collagen

Thrombosis Research

Volumn 127, Issue SUPPL. 2, 2011, Pages

  Nuyttens, Benedicte P ^a   Thijs, Tim ^a   Deckmyn, Hans ^a   Broos, Katleen ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

2 1; collagen; GPIb; GPVI; Platelets; VWF

Indexed keywords

COLLAGEN; GLYCOPROTEIN VI; VERY LATE ACTIVATION ANTIGEN 2; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; HEMOSTASIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; THROMBOCYTE ADHESION; THROMBOGENESIS;

COLLAGEN; ENDOTHELIUM, VASCULAR; HEMOSTASIS; HUMANS; INTEGRIN ALPHA2BETA1; MODELS, MOLECULAR; PLATELET ADHESIVENESS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN STRUCTURE, TERTIARY; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 78650793802     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(10)70151-1     Document Type: Article

References (46)

1. JM van Gils, JJ Zwaginga, PL Hordijk Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases J Leukoc Biol 85 2009 195 204
2. RA Kumar, JF Dong, JA Thaggard, MA Cruz, JA Lopez, LV McIntire Kinetics of GPIb alpha-vWF-A1 tether bond under flow: Effect of GPIb alpha mutations on the association and dissociation rates Biophys J 85 2003 4099 4109
3. N Pugh, AM Simpson, PA Smethurst, PG de Groot, N Raynal, RW Farndale Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood Blood 115 2010 5069 5079
4. ZM Ruggeri, GL Mendolicchio Adhesion mechanisms in platelet function Circ Res 100 2007 1673 1685
5. S Konstantinides, J Ware, P Marchese, F Almus-Jacobs, DJ Loskutoff, ZM Ruggeri Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis J Thromb Haemost 4 2006 2014 2021
6. B Savage, F Almus-Jacobs, ZM Ruggeri Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow Cell 94 1998 657 666
7. ZM Ruggeri Von Willebrand factor: Looking back and looking forward Thromb Haemost 98 2007 55 62
8. H Ulrichts, M Udvardy, PJ Lenting, I Pareyn, N Vandeputte, K Vanhoorelbeke Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V J Biol Chem 281 2006 4699 4707
9. T Lisman, N Raynal, D Groeneveld, B Maddox, AR Peachey, EG Huizinga A single high-affinity binding site for von Willebrand Factor in collagen III, identified using synthetic triple-helical peptides Blood 108 2006 3753 3756
10. C Denis, N Methia, PS Frenette, H Rayburn, M Ullman-Cullere, RO Hynes A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis Proc Natl Acad Sci U S A 95 1998 9524 9529
11. W Bergmeier, CL Piffath, T Goerge, SM Cifuni, ZM Ruggeri, J Ware The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis Proc Natl Acad Sci U S A 103 2006 16900 16905
12. SZ Luo, X Mo, V Afshar-Kharghan, S Srinivasan, JA López, R Li Glycoprotein Ibal-pha forms disulfide bonds with 2 glycoprotein Ibbeta subunits in the resting platelet Blood 109 2007 603 609
13. JJ Dumas, R Kumar, T McDonagh, F Sullivan, ML Stahl, WS Somers Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations J Biol Chem 279 2004 23327 23334
14. EG Huizinga, S Tsuji, RA Romijn, ME Schiphorst, PG de Groot, JJ Sixma Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain Science 297 2002 1176 1179
15. XP Du Signaling and regulation of the platelet glycoprotein Ib-IX-V complex Curr Opin Hematol 14 2007 262 269
16. D Wu, K Vanhoorelbeke, N Cauwenberghs, M Meiring, H Depraetere, HF Kotze Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons Blood 99 2002 3623 3628
17. J Bartunek, E Barbato, JB Holz, K Vercruysse, H Ulrichts, G Heyndrickx ALX-0081 a novel anti-thrombotic: results of a single-dose phase 1 study in healthy volunteers and further development in patients with stable angina undergoing PCI Circulation 118 2008 S656
18. N Cauwenberghs, M Meiring, S Vauterin, V van Wijk, S Lamprecht, JP Roodt Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates Arterioscler Thromb Vasc Biol 20 2000 1347 1353
19. P Knobl, B Jilma, JC Gilbert, RM Hutabarat, PG Wagner, P Jilma-Stohlawetz Anti-von Willebrand factor aptamer ARC1779 for refractory thrombotic thrombocytopenic purpura Transfusion 49 2009 2181 2185
20. M Moroi, SM Jung Platelet glycoprotein VI: its structure and function Thromb Res 114 2004 221 233
21. K Horii, ML Kahn, AB Herr Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI Blood 108 2006 936 942
22. CG Knight, LF Morton, DJ Onley, AR Peachey, T Ichinohe, M Okuma Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen Cardiovasc Res 41 1999 450 457
23. SP Watson, JM Herbert, AY Pollitt GPVI and CLEC-2 in haemostasis and vascular integrity J Thromb Haemost 8 2010 1456 1467
24. Y Matsumoto, H Takizawa, K Nakama, X Gong, Y Yamada, NN Tandon Ex vivo evaluation of anti-GPVI antibody in cynomolgus monkeys: dissociation between anti-platelet aggregatory effect and bleeding time Thromb Haemost 96 2006 167 175
25. P Ohlmann, B Hechler, C Ravanat, S Loyau, N Herrenschmidt, F Wanert Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression J Thromb Haemost 6 2008 1003 1011
26. A Walker, N Pugh, SF Garner, J Stephens, B Maddox, WH Ouwehand Single domain antibodies against the collagen signalling receptor glycoprotein VI are inhibitors of collagen induced thrombus formation Platelets 20 2009 268 276
27. K Ono, H Ueda, Y Yoshizawa, D Akazawa, R Tanimura, I Shimada Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI J Med Chem 53 2010 2087 2093
28. JF Arthur, S Dunkley, RK Andrews Platelet glycoprotein VI-related clinical defects Br J Haematol 139 2007 363 372
29. H Deckmyn, SL Chew, J Vermylen Lack of platelet response to collagen associated with an autoantibody against glycoprotein Ia: a novel cause of acquired qualitative platelet dysfunction Thromb Haemost 64 1990 74 79
30. HK Nieuwenhuis, JW Akkerman, WP Houdijk, JJ Sixma Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia Nature 318 1985 470 472
31. AB Herr, RW Farndale Structural insights into the interactions between platelet receptors and fibrillar collagen J Biol Chem 284 2009 19781 19785
32. J Emsley, CG Knight, RW Farndale, MJ Barnes, RC Liddington Structural basis of collagen recognition by integrin alpha2beta1 Cell 101 2000 47 56
33. A Schoolmeester, K Vanhoorelbeke, S Katsutani, H Depraetere, HB Feys, JM Heemskerk Monoclonal antibody IAC-1 is specific for activated {alpha}2{beta}1 and binds to amino acids 199 to 201 of the integrin {alpha}2 I-domain Blood 104 2004 390 396
34. GR Van de Walle, K Vanhoorelbeke, Z Majer, E Illyes, J Baert, I Pareyn Two functional active conformations of the integrin alpha2 beta 1, depending on activation condition and cell type J Biol Chem 280 2005 36873 36882
35. DA Calderwood, Y Fujioka, JM de Pereda, B Garcia-Alvarez, T Nakamoto, B Margolis Integrin beta cytoplasmic domain interactions with phosphotyrosine- binding domains: A structural prototype for diversity in integrin signaling Proc Natl Acad Sci U S A 100 2003 2272 2277
36. B Nieswandt, M Moser, I Pleines, D Varga-Szabo, S Monkley, D Critchley Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo J Exp Med 204 2007 3113 3118
37. A Banno, MH Ginsberg Integrin activation Biochem Soc Trans 36 2008 229 234
38. DS Harburger, M Bouaouina, DA Calderwood Kindlin-1 and -2 directly bind the C-terminal region of beta integrin cytoplasmic tails and exert integrin-specific activation effects J Biol Chem 284 2009 11485 11497
39. M Moser, B Nieswandt, S Ussar, M Pozgajova, R Fassler Kindlin-3 is essential for integrin activation and platelet aggregation Nat Med 14 2008 325 330
40. K Vanhoorelbeke, H Ulrichts, A Schoolmeester, H Deckmyn Inhibition of platelet adhesion to collagen as a new target for antithrombotic drugs Curr Drug Targets Cardiovasc Haematol Disord 3 2003 125 140
41. B Nieswandt, C Brakebusch, W Bergmeier, V Schulte, D Bouvard, R Mokhtari-Nejad Glycoprotein VI but not alpha 2 beta 1 integrin is essential for platelet interaction with collagen EMBO J 20 2001 2120 2130
42. PRM Siljander, ICA Munnix, PA Smethurst, H Deckmyn, T Lindhout, WH Ouwehand Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood Blood 103 2004 1333 1341
43. NN Tandon, U Kralisz, GA Jamieson Identification of glycoprotein-IV (Cd36) as a primary receptor for platelet-collagen adhesion J Biol Chem 264 1989 7576 7583
44. E Monnet, H Depraetere, C Legrand, H Deckmyn, F Fauvel-Lafeve A monoclonal antibody to platelet type III collagen-binding protein (TIIICBP) binds to blood and vascular cells, and inhibits platelet vessel-wall interactions Thromb Haemost 86 2001 694 701
45. TM Chiang, J Zhu, V Woo-Rasberry Peptides derived from platelet non-integrin collagen-receptors or types I and III collagen inhibit collagen-platelet interaction Cardiovasc Hematol Disord Drug Targets 7 2010 71 75
46. II Salles, T Thijs, C Brunaud, SF De Meyer, J Thys, K Vanhoorelbeke Human platelets produced in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice upon transplantation of human cord blood CD34(+) cells are functionally active in an ex vivo flow model of thrombosis Blood 114 2009 5044 5051